America’s First Ibogaine Microdose Treatment Center Opening in 2026

### America’s First Ibogaine Microdose Treatment Center:

In 2026, the United States will open its first ibogaine microdose treatment center — a pioneering space where science, spirit, and compassion unite to heal the roots of human suffering. This landmark center will offer a new approach for those living with addiction, PTSD, traumatic brain injury, and Parkinson’s disease, combining cutting-edge neuroscience with deep emotional and spiritual integration.
Unlike traditional high-dose ibogaine sessions, microdosing allows for gentle, sustained healing — supporting neurochemical balance, emotional clarity, and renewed vitality without the intensity of a full visionary experience. Early studies and global data suggest that ibogaine in microdoses can rebuild neural pathways, restore dopamine sensitivity, and calm the nervous system, helping the body and soul remember what peace feels like.
This breakthrough arrives at a time when millions are searching for more than just medication — they are searching for meaning. By nurturing both the heart and the brain, this new ibogaine center represents a sanctuary for transformation, not just treatment. It is where trauma finds understanding, where addiction meets compassion, and where science meets the sacred.
With California Assembly Bill 1103 (AB 1103) — signed by Governor Gavin Newsom — creating the legal pathway for psychedelic-assisted care, California is once again leading the nation toward a future where healing is human-centered, safe, and profoundly effective.
The first U.S. ibogaine microdose treatment center is more than a medical milestone — it is a movement of hope, proving that true recovery doesn’t just restore the mind; it reawakens the soul.

Share this with someone you care about and Message me for more information about our facility in Northern California.